Clinical Use of Aromatase Inhibitors: Current Data and Future Perspectives
- 1 January 1990
- journal article
- review article
- Published by Taylor & Francis in Journal of Enzyme Inhibition
- Vol. 4 (2) , 79-99
- https://doi.org/10.3109/14756369009040730
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- A phase I trial of CGS 16949a. A new aromatase inhibitorCancer, 1990
- Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Aromatase inhibition by the antifungal ketoconazoleJournal of Steroid Biochemistry, 1988
- On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancerJournal of Molecular Medicine, 1987
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: Relationship to receptor contentPublished by Elsevier ,1980
- Serum Aminoglutethimide Levels: Studies of Serum Half‐Life, Clearance, and Patient ComplianceThe Journal of Clinical Pharmacology, 1979
- Estrone and estradiol content in human breast tumors: Relationship to estradiol receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1977
- Preliminary trial of aminoglutethimide in breast cancerCancer, 1973